Skip to content

Advent International, L.P.: ARES position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Advent International, L.P. on ARES, newest first. How the timeline and the estimate are built.

Advent International, L.P. held 445,570 ARES shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 445,570 shares
    Change vs previous 13F +16,850 shares

    0.28% of the 13F portfolio, value $49,596,397.

    13F-HR 0001193125-26-352544 filed by Advent International, L.P.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 428,720 shares
    Change vs previous 13F +424,185 shares

    1.1% of the 13F portfolio, value $46,773,352.

    13F-HR 0001193125-26-227070 filed by Advent International, L.P.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 4,535 shares
    Change vs previous 13F -32,200 shares

    0.02% of the 13F portfolio, value $732,992.

    13F-HR 0001193125-26-055026 filed by Advent International, L.P.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 36,735 shares
    Change vs previous 13F -120,800 shares

    0.12% of the 13F portfolio, value $5,873,559.

    13F-HR 0001193125-25-282954 filed by Advent International, L.P.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 157,535 shares
    Change vs previous 13F not available

    0.89% of the 13F portfolio, value $27,285,062.

    13F-HR 0000950123-25-008331 filed by Advent International, L.P.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).